Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *Mycobacterium tuberculosis* cell wall synthesis pathway comprises numerous enzymes responsible for assembling a unique, lipid-rich, multi-layered envelope. This cell wall is made up of three main components: a peptidoglycan layer, an arabinogalactan polysaccharide, and a mycolic acid outer layer, with additional complex glycolipids and free lipids[2][3][4][6][7]. The cell wall’s structure furnishes *M. tuberculosis* with resilience to environmental stresses, resistance to both host immunity and antibiotics, and is directly implicated in the organism’s virulence and persistence. Because of its essential role in bacterial survival and pathogenesis, enzymes and processes in this pathway are the most widely exploited targets for both first-line and novel anti-tuberculosis drugs. However, drug resistance and challenges in drug delivery due to the impermeable barrier remain major obstacles to effective therapy[4][3][7].
Inhibition of mycolic acid synthesis; Inhibition of arabinogalactan synthesis; Inhibition of peptidoglycan synthesis; Disruption of cell wall assembly
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis cell wall synthesis pathway.